GITNUXREPORT 2026

Rehab Industry Statistics

The rehab industry is growing as addiction rates rise, yet treatment remains costly and inaccessible.

Alexander Schmidt

Alexander Schmidt

Research Analyst specializing in technology and digital transformation trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Key Statistics

Statistic 1

Approximately 46.8 million people aged 12+ had a substance use disorder (SUD) in the U.S. in 2021, equating to 16.5% of the population.

Statistic 2

Opioid use disorder affected 6.1 million Americans in 2022, with 80% starting with prescription painkillers.

Statistic 3

Alcohol use disorder prevalence was 29.5 million adults in the U.S. in 2021, or 10.6% of those aged 18+.

Statistic 4

Among U.S. adults, 5.1 million had cocaine use disorder in 2022, highest among 18-25 year olds at 1.2% prevalence.

Statistic 5

2.7 million youth aged 12-17 experienced marijuana use disorder in 2021, representing 7.0% of that age group.

Statistic 6

Native Americans had the highest SUD rate at 25.8% in 2021, compared to 16.2% for Whites and 14.5% for Blacks.

Statistic 7

Women comprised 38% of rehab admissions in 2022, with rising fentanyl overdoses at 45% female victims.

Statistic 8

Rural areas saw 20% higher opioid addiction rates than urban in 2023, affecting 2.4 million residents.

Statistic 9

Veterans had 11.3% SUD prevalence in 2022, with PTSD comorbidity in 50% of cases.

Statistic 10

LGBTQ+ individuals reported 20-30% higher substance misuse rates, with 25% lifetime AUD prevalence.

Statistic 11

65% of rehabs reported staff turnover rates exceeding 40% annually in 2022 due to burnout.

Statistic 12

Regulatory compliance violations occurred in 28% of facilities inspected by DEA in 2023.

Statistic 13

Cyberattacks on rehab EHR systems rose 300% from 2020-2023, exposing 1.5 million records.

Statistic 14

Shortage of certified addiction counselors left 35% of positions unfilled in 2022.

Statistic 15

Insurance denials for SUD treatment increased 22% in 2023, averaging 15 denials per claim.

Statistic 16

Fentanyl crisis drove 40% increase in demand for detox beds since 2020.

Statistic 17

75% of rehabs adopted AI-driven relapse prediction tools by 2023.

Statistic 18

Stigma reduced help-seeking by 60%, with only 1 in 10 addicts entering treatment voluntarily.

Statistic 19

Climate events disrupted 12% of rural rehabs in 2022, causing service gaps.

Statistic 20

Rise of psychedelic-assisted therapy in 25% of progressive rehabs despite FDA hurdles.

Statistic 21

Malpractice lawsuits against rehabs climbed 18% in 2023, focused on negligence claims.

Statistic 22

Post-COVID, 50% of rehabs faced funding cuts from philanthropy drops.

Statistic 23

The U.S. rehab industry market size reached $7.5 billion in 2023, with a CAGR of 6.8% from 2018-2023 driven by rising opioid addiction rates.

Statistic 24

Global addiction rehabilitation services market was valued at $48.2 billion in 2022, projected to grow to $74.5 billion by 2030 at 5.6% CAGR.

Statistic 25

Inpatient rehab facilities in the U.S. generated $35.4 billion in revenue in 2021, accounting for 74% of total rehab industry earnings.

Statistic 26

Outpatient rehab services revenue hit $12.1 billion in 2022, growing 8.2% year-over-year due to telehealth integration post-COVID.

Statistic 27

The rehab industry employed 215,000 full-time workers in the U.S. as of 2023, with average annual salary of $52,300 for counselors.

Statistic 28

Private rehab centers charged an average of $55,000 for 30-day inpatient programs in 2023, up 12% from 2020.

Statistic 29

Insurance reimbursements covered 62% of rehab costs in 2022, with Medicare/Medicaid funding $18.7 billion for SUD treatment.

Statistic 30

Venture capital investment in digital rehab startups reached $1.2 billion in 2023, focusing on app-based sobriety tools.

Statistic 31

U.S. rehab bed capacity stood at 85,000 in 2022, with 92% occupancy rate amid waitlists averaging 14 days.

Statistic 32

Luxury rehab market segment grew 15% in 2023 to $2.8 billion, targeting high-net-worth individuals with holistic therapies.

Statistic 33

U.S. rehab industry market size reached $7.5 billion in 2023, with a CAGR of 6.8% from 2018-2023 driven by rising opioid addiction rates.

Statistic 34

Global addiction rehabilitation services market was valued at $48.2 billion in 2022, projected to grow to $74.5 billion by 2030 at 5.6% CAGR.

Statistic 35

Inpatient rehab facilities in the U.S. generated $35.4 billion in revenue in 2021, accounting for 74% of total rehab industry earnings.

Statistic 36

Outpatient rehab services revenue hit $12.1 billion in 2022, growing 8.2% year-over-year due to telehealth integration post-COVID.

Statistic 37

The rehab industry employed 215,000 full-time workers in the U.S. as of 2023, with average annual salary of $52,300 for counselors.

Statistic 38

Private rehab centers charged an average of $55,000 for 30-day inpatient programs in 2023, up 12% from 2020.

Statistic 39

Insurance reimbursements covered 62% of rehab costs in 2022, with Medicare/Medicaid funding $18.7 billion for SUD treatment.

Statistic 40

Venture capital investment in digital rehab startups reached $1.2 billion in 2023, focusing on app-based sobriety tools.

Statistic 41

U.S. rehab bed capacity stood at 85,000 in 2022, with 92% occupancy rate amid waitlists averaging 14 days.

Statistic 42

90-day rehab completion rates averaged 58% in 2022, with sustained sobriety at 40% after one year.

Statistic 43

MAT with buprenorphine reduced overdose deaths by 50% among treated patients in 2021 studies.

Statistic 44

Cognitive Behavioral Therapy (CBT) in rehab yielded 60% relapse prevention at 6 months vs. 40% without.

Statistic 45

Contingency management programs boosted abstinence rates to 75% during treatment in 2022 trials.

Statistic 46

Dual diagnosis treatment for co-occurring mental health improved 1-year recovery rates to 55%.

Statistic 47

Long-term residential rehab (90+ days) had 28% better 5-year sobriety than short-term (68% vs. 40%).

Statistic 48

Aftercare program participation increased 2-year sobriety to 70% from 35% without support.

Statistic 49

Sober living homes achieved 76% employment rate among residents post-rehab in 2023.

Statistic 50

Family-involved rehab interventions reduced relapse by 25% at 12 months follow-up.

Statistic 51

Mindfulness-based relapse prevention maintained 49% abstinence at 15 months vs. 20% control.

Statistic 52

Gender-specific rehab programs showed 15% higher completion rates for women (65% vs. 50%).

Statistic 53

Holistic therapies like yoga in rehab correlated with 30% lower anxiety scores and better retention.

Statistic 54

55% of alumni from accredited rehabs maintained sobriety at 1 year with peer support groups.

Statistic 55

Vivitrol (naltrexone) extended-release reduced opioid relapse to 36% vs. 54% oral meds.

Statistic 56

Employment post-rehab predicted 80% lower relapse risk over 3 years.

Statistic 57

Adolescent rehab success rates hit 50% at 1 year with family therapy integration.

Statistic 58

70.4% of U.S. adults with SUD received no treatment in 2021, citing cost and stigma as top barriers.

Statistic 59

Only 10.4% of the 46.8 million with SUD accessed specialty treatment facilities in 2022.

Statistic 60

Telehealth SUD treatment visits surged 154% from 2019 to 2022, serving 4.2 million patients.

Statistic 61

Medicaid expansion states had 25% higher SUD treatment admission rates, totaling 1.8 million in 2021.

Statistic 62

Wait times for publicly funded rehab averaged 37 days in 2023, vs. 5 days for private pay.

Statistic 63

42% of rehab facilities offered medication-assisted treatment (MAT) for opioids in 2022.

Statistic 64

Employer-sponsored EAPs referred 1.2 million to rehab in 2022, covering 55% of workforce.

Statistic 65

Prison-based SUD treatment reached 250,000 inmates in 2021, reducing recidivism by 43%.

Statistic 66

Faith-based rehab programs served 15% of admissions in 2022, with 80% 12-step model adherence.

Statistic 67

Only 6% of physicians received SUD treatment training, limiting primary care referrals.

Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
Behind the staggering statistics of a $74.5 billion global industry lies a sobering reality: the addiction crisis is not just growing, it's reshaping a field strained by immense demand, critical staff shortages, and a desperate race against time for millions seeking recovery.

Key Takeaways

  • The U.S. rehab industry market size reached $7.5 billion in 2023, with a CAGR of 6.8% from 2018-2023 driven by rising opioid addiction rates.
  • Global addiction rehabilitation services market was valued at $48.2 billion in 2022, projected to grow to $74.5 billion by 2030 at 5.6% CAGR.
  • Inpatient rehab facilities in the U.S. generated $35.4 billion in revenue in 2021, accounting for 74% of total rehab industry earnings.
  • Approximately 46.8 million people aged 12+ had a substance use disorder (SUD) in the U.S. in 2021, equating to 16.5% of the population.
  • Opioid use disorder affected 6.1 million Americans in 2022, with 80% starting with prescription painkillers.
  • Alcohol use disorder prevalence was 29.5 million adults in the U.S. in 2021, or 10.6% of those aged 18+.
  • 70.4% of U.S. adults with SUD received no treatment in 2021, citing cost and stigma as top barriers.
  • Only 10.4% of the 46.8 million with SUD accessed specialty treatment facilities in 2022.
  • Telehealth SUD treatment visits surged 154% from 2019 to 2022, serving 4.2 million patients.
  • 90-day rehab completion rates averaged 58% in 2022, with sustained sobriety at 40% after one year.
  • MAT with buprenorphine reduced overdose deaths by 50% among treated patients in 2021 studies.
  • Cognitive Behavioral Therapy (CBT) in rehab yielded 60% relapse prevention at 6 months vs. 40% without.
  • 65% of rehabs reported staff turnover rates exceeding 40% annually in 2022 due to burnout.
  • Regulatory compliance violations occurred in 28% of facilities inspected by DEA in 2023.
  • Cyberattacks on rehab EHR systems rose 300% from 2020-2023, exposing 1.5 million records.

The rehab industry is growing as addiction rates rise, yet treatment remains costly and inaccessible.

Addiction Prevalence and Demographics

  • Approximately 46.8 million people aged 12+ had a substance use disorder (SUD) in the U.S. in 2021, equating to 16.5% of the population.
  • Opioid use disorder affected 6.1 million Americans in 2022, with 80% starting with prescription painkillers.
  • Alcohol use disorder prevalence was 29.5 million adults in the U.S. in 2021, or 10.6% of those aged 18+.
  • Among U.S. adults, 5.1 million had cocaine use disorder in 2022, highest among 18-25 year olds at 1.2% prevalence.
  • 2.7 million youth aged 12-17 experienced marijuana use disorder in 2021, representing 7.0% of that age group.
  • Native Americans had the highest SUD rate at 25.8% in 2021, compared to 16.2% for Whites and 14.5% for Blacks.
  • Women comprised 38% of rehab admissions in 2022, with rising fentanyl overdoses at 45% female victims.
  • Rural areas saw 20% higher opioid addiction rates than urban in 2023, affecting 2.4 million residents.
  • Veterans had 11.3% SUD prevalence in 2022, with PTSD comorbidity in 50% of cases.
  • LGBTQ+ individuals reported 20-30% higher substance misuse rates, with 25% lifetime AUD prevalence.

Addiction Prevalence and Demographics Interpretation

Behind these staggering statistics lies a national truth we can no longer afford to ignore: we are prescribing, self-medicating, and numbing our collective pain on an industrial scale, from the legacy of our veterans to the futures of our youth.

Industry Trends and Challenges

  • 65% of rehabs reported staff turnover rates exceeding 40% annually in 2022 due to burnout.
  • Regulatory compliance violations occurred in 28% of facilities inspected by DEA in 2023.
  • Cyberattacks on rehab EHR systems rose 300% from 2020-2023, exposing 1.5 million records.
  • Shortage of certified addiction counselors left 35% of positions unfilled in 2022.
  • Insurance denials for SUD treatment increased 22% in 2023, averaging 15 denials per claim.
  • Fentanyl crisis drove 40% increase in demand for detox beds since 2020.
  • 75% of rehabs adopted AI-driven relapse prediction tools by 2023.
  • Stigma reduced help-seeking by 60%, with only 1 in 10 addicts entering treatment voluntarily.
  • Climate events disrupted 12% of rural rehabs in 2022, causing service gaps.
  • Rise of psychedelic-assisted therapy in 25% of progressive rehabs despite FDA hurdles.
  • Malpractice lawsuits against rehabs climbed 18% in 2023, focused on negligence claims.
  • Post-COVID, 50% of rehabs faced funding cuts from philanthropy drops.

Industry Trends and Challenges Interpretation

Despite heroic attempts to automate recovery and expand beds, the rehab industry is buckling under a perfect storm of fleeing staff, relentless denials, and a society that still treats addiction more as a crime than a crisis.

Market and Economic Data

  • The U.S. rehab industry market size reached $7.5 billion in 2023, with a CAGR of 6.8% from 2018-2023 driven by rising opioid addiction rates.
  • Global addiction rehabilitation services market was valued at $48.2 billion in 2022, projected to grow to $74.5 billion by 2030 at 5.6% CAGR.
  • Inpatient rehab facilities in the U.S. generated $35.4 billion in revenue in 2021, accounting for 74% of total rehab industry earnings.
  • Outpatient rehab services revenue hit $12.1 billion in 2022, growing 8.2% year-over-year due to telehealth integration post-COVID.
  • The rehab industry employed 215,000 full-time workers in the U.S. as of 2023, with average annual salary of $52,300 for counselors.
  • Private rehab centers charged an average of $55,000 for 30-day inpatient programs in 2023, up 12% from 2020.
  • Insurance reimbursements covered 62% of rehab costs in 2022, with Medicare/Medicaid funding $18.7 billion for SUD treatment.
  • Venture capital investment in digital rehab startups reached $1.2 billion in 2023, focusing on app-based sobriety tools.
  • U.S. rehab bed capacity stood at 85,000 in 2022, with 92% occupancy rate amid waitlists averaging 14 days.
  • Luxury rehab market segment grew 15% in 2023 to $2.8 billion, targeting high-net-worth individuals with holistic therapies.
  • U.S. rehab industry market size reached $7.5 billion in 2023, with a CAGR of 6.8% from 2018-2023 driven by rising opioid addiction rates.
  • Global addiction rehabilitation services market was valued at $48.2 billion in 2022, projected to grow to $74.5 billion by 2030 at 5.6% CAGR.
  • Inpatient rehab facilities in the U.S. generated $35.4 billion in revenue in 2021, accounting for 74% of total rehab industry earnings.
  • Outpatient rehab services revenue hit $12.1 billion in 2022, growing 8.2% year-over-year due to telehealth integration post-COVID.
  • The rehab industry employed 215,000 full-time workers in the U.S. as of 2023, with average annual salary of $52,300 for counselors.
  • Private rehab centers charged an average of $55,000 for 30-day inpatient programs in 2023, up 12% from 2020.
  • Insurance reimbursements covered 62% of rehab costs in 2022, with Medicare/Medicaid funding $18.7 billion for SUD treatment.
  • Venture capital investment in digital rehab startups reached $1.2 billion in 2023, focusing on app-based sobriety tools.
  • U.S. rehab bed capacity stood at 85,000 in 2022, with 92% occupancy rate amid waitlists averaging 14 days.

Market and Economic Data Interpretation

As human suffering becomes an ever-more lucrative growth industry, the grim arithmetic of addiction reveals a market where beds are nearly full, prices are steeply climbing, and desperate demand is reliably outpacing our capacity to provide genuinely accessible care.

Recovery Outcomes and Success Rates

  • 90-day rehab completion rates averaged 58% in 2022, with sustained sobriety at 40% after one year.
  • MAT with buprenorphine reduced overdose deaths by 50% among treated patients in 2021 studies.
  • Cognitive Behavioral Therapy (CBT) in rehab yielded 60% relapse prevention at 6 months vs. 40% without.
  • Contingency management programs boosted abstinence rates to 75% during treatment in 2022 trials.
  • Dual diagnosis treatment for co-occurring mental health improved 1-year recovery rates to 55%.
  • Long-term residential rehab (90+ days) had 28% better 5-year sobriety than short-term (68% vs. 40%).
  • Aftercare program participation increased 2-year sobriety to 70% from 35% without support.
  • Sober living homes achieved 76% employment rate among residents post-rehab in 2023.
  • Family-involved rehab interventions reduced relapse by 25% at 12 months follow-up.
  • Mindfulness-based relapse prevention maintained 49% abstinence at 15 months vs. 20% control.
  • Gender-specific rehab programs showed 15% higher completion rates for women (65% vs. 50%).
  • Holistic therapies like yoga in rehab correlated with 30% lower anxiety scores and better retention.
  • 55% of alumni from accredited rehabs maintained sobriety at 1 year with peer support groups.
  • Vivitrol (naltrexone) extended-release reduced opioid relapse to 36% vs. 54% oral meds.
  • Employment post-rehab predicted 80% lower relapse risk over 3 years.
  • Adolescent rehab success rates hit 50% at 1 year with family therapy integration.

Recovery Outcomes and Success Rates Interpretation

The rehab industry's statistics reveal a clear, if sobering, recipe: combine medical pragmatism like medication-assisted treatment with structured psychological support and relentless aftercare to build a bridge from the 58% who finish treatment to the far fewer who actually walk the path of long-term recovery.

Treatment Utilization and Access

  • 70.4% of U.S. adults with SUD received no treatment in 2021, citing cost and stigma as top barriers.
  • Only 10.4% of the 46.8 million with SUD accessed specialty treatment facilities in 2022.
  • Telehealth SUD treatment visits surged 154% from 2019 to 2022, serving 4.2 million patients.
  • Medicaid expansion states had 25% higher SUD treatment admission rates, totaling 1.8 million in 2021.
  • Wait times for publicly funded rehab averaged 37 days in 2023, vs. 5 days for private pay.
  • 42% of rehab facilities offered medication-assisted treatment (MAT) for opioids in 2022.
  • Employer-sponsored EAPs referred 1.2 million to rehab in 2022, covering 55% of workforce.
  • Prison-based SUD treatment reached 250,000 inmates in 2021, reducing recidivism by 43%.
  • Faith-based rehab programs served 15% of admissions in 2022, with 80% 12-step model adherence.
  • Only 6% of physicians received SUD treatment training, limiting primary care referrals.

Treatment Utilization and Access Interpretation

Despite telehealth’s meteoric rise and proven solutions like MAT, our addiction treatment system remains a paradoxical and underfunded labyrinth where your zip code, wallet, and employer benefits determine whether you face a 37-day wait or a five-day pass.

Sources & References